ArticleHeliyon2024

Real-world evidence for brolucizumab efficacy in age-related macular degeneration and central serous chorioretinopathy patients.

Samoila Lacramioara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.